🔗 Share this article

An underground market for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.

Investigational Drug Acquiring Popularity Online

The experimental drug, which remains in research studies, is being promoted by online personalities for its alleged weight-reducing effects. Viewers are encouraged to contact these accounts privately for source information, while also receiving promotional offers.

Active Trade on Social Networks

Separately, a flourishing trade exists on messaging services, where communities with thousands of participants share “before and after” photos, injection guides and assertions of rapid UK delivery. Vendors market the substance there before redirecting customers to other platforms for purchases.

Learning About The Experimental Drug

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.

Healthcare Professionals Voice Concerns

However, physicians and chemists have cautions that the distribution of what is still an unlicensed drug in the UK is a cause for concern and could lead to individuals injecting substances of unknown origin.

Some experts stated the demand for the experimental drug could be linked to the increasing price of approved weight loss treatments such as Mounjaro.

Legal Position and Enforcement

Selling retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.

Several content creators attempt to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still breach pharmaceutical, marketing, and consumer regulations, risking penalties, prosecution or prison.

Service Reaction and Material Elimination

According to the social media company, the service has taken down problematic material and banned associated hashtags and search suggestions. The organization stated it was dedicated to keeping the service safe and investing in enhancing enforcement strategies.

Online Trading Activities

Research also discovered communities with up to nine thousand members selling the experimental drug using the platform's integrated discovery tool, which functions like a public directory. Typing “retatrutide” instantly displays groups with thousands of users, filled with images of slimming results, glowing testimonials and step-by-step instructions for preparing or administering at home.

Within moments of joining one group, a seller shared contact information, where most purchases take place. The seller sent an guidebook and promised shipping within 48 hours. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a image of a alleged testing documentation. None asked about body mass, health issues or past usage.

Product Details and Costs

Within these communities, messages show black plastic packages with Royal Mail labels, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at residence with purified liquid, or ready-to-use pens usually priced at £160 for 20mg. When asked how much time a injector should be used, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Oversight and Safety Actions

A spokesperson for the messaging service stated it actively moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering materials they can’t verify. Even if the science behind retatrutide is valid, these online versions may not include what they advertise,” stated Jason Murphy, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to recent price rises for authorized weight-loss drugs such as Mounjaro. “With prices increasing, patients are using social media. But counterfeit injections are extremely risky. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she said.

Her team has already encountered individuals injured by self-injection from unverified suppliers. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your health,” stated the doctor. “These substances could be impure or improperly measured.”

Manufacturer Statement

A representative from the pharmaceutical company stated the substance was in third stage research studies and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a Lilly investigational substance not yet approved … may subject patients to potentially serious medical dangers”.